Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: A retrospective study

Interdisciplinary Perspectives on Infectious Diseases

Volumn 2012, Issue , 2012, Pages

  Lueangarun, Saoraya ^a   Leelarasamee, Amorn ^b  

^a CHULABHORN GRADUATE INSTITUTE   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; DORIPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; APACHE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK;

EID: 84866170652     PISSN: 1687708X     EISSN: 16877098     Source Type: Journal    
DOI: 10.1155/2012/765205     Document Type: Article

References (68)

1. Angkasekwinai N., Rattanaumpawan P., Thamlikitkul V., Epidemiology of sepsis in Siriraj Hospital 2007. Journal of the Medical Association of Thailand 2009 92, supplement 2 S68 S78 2-s2.0-67651227304
2. Kumar A., Ellis P., Arabi Y., Roberts D., Light B., Parrillo J. E., Dodek P., Wood G., Kumar A., Simon D., Peters C., Ahsan M., Chateau D., Wood K. E., Laupland K., Kramer A., Sharma S., Lapinsky S., Marshall J., Dial S., Skrobik I., Patel G., Gurka D., Zanotti S., Dellinger R. P., Feinstein D., Guzman J., Al Shirawi N., Al Memish Z., Ronald J., Suleman M., Gulati H., Halmarson E., Suppes R., Sullivan K., Bohmeier R., Muggaberg S., Kravetsky L., Singh A., Carter L., Wiebe K., Kolesar L., Richards J., Jaswal D., Chou H., Kosick T., Fu W., Chan C., Ren J. J., Bahrainian M., Haque Z., Torshizi O. A., Paulin H., Khan F., Kumar R., Harvey J., Kim C., Li J., Campbell L., Taiberg L., Schorr C., Tchokonte R., Gonzales C., Serrano N., Delgra S., Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009 136 5 1237 1248 2-s2.0-70350580290 10.1378/chest.09- 0087
3. Gaieski D. F., Mikkelsen M. E., Band R. A., Pines J. M., Massone R., Furia F. F., Shofer F. S., Goyal M., Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Critical Care Medicine 2010 38 4 1045 1053 2-s2.0-77950218147 10.1097/CCM.0b013e3181cc4824
4. Kumar A., Roberts D., Wood K. E., Light B., Parrillo J. E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A., Cheang M., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine 2006 34 6 1589 1596 2-s2.0-33744527833 10.1097/01.CCM.0000217961.75225. E9 (Pubitemid 43810035)
5. Dellinger R. P., Levy M. M., Carlet J. M., Bion J., Parker M. M., Jaeschke R., Reinhart K., Angus D. C., Brun-Buisson C., Beale R., Calandra T., Dhainaut J. F., Gerlach H., Harvey M., Marini J. J., Marshall J., Ranieri M., Ramsay G., Sevransky J., Thompson B. T., Townsend S., Vender J. S., Zimmerman J. L., Vincent J. L., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine 2008 36 1 296 327 2-s2.0-37549020378 10.1097/01.CCM.0000298158.12101.41
6. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 1992 101 6 1644 1655
7. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E., APACHE II: a severity of disease classification system. Critical Care Medicine 1985 13 10 818 829 2-s2.0-0022256529 (Pubitemid 15250137)
8. Garner J. S., Jarvis W. R., Emori T. G., Horan T. C., Hughes J. M., CDC Defionitions for nosocomial infections, 1988. American Journal of Infection Control 1988 16 3 128 140 2-s2.0-0023821657
9. Bochud P. Y., Bonten M., Marchetti O., Calandra T., Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Critical Care Medicine 2004 32 11, supplement S495 S512 2-s2.0-8444238164 10.1097/01.CCM.0000143118.41100.14 (Pubitemid 39489023)
10. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J. L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B (Pubitemid 36444440)
11. Kumar A., Zarychanski R., Light B., Parrillo J., Maki D., Simon D., Laporta D., Lapinsky S., Ellis P., Mirzanejad Y., Martinka G., Keenan S., Wood G., Arabi Y., Feinstein D., Kumar A., Dodek P., Kravetsky L., Doucette S., Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Critical Care Medicine 2010 38 9 1773 1785 2-s2.0-77956226360 10.1097/CCM.0b013e3181eb3ccd
12. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2005 171 4 388 416 10.1164/rccm.200405- 644ST (Pubitemid 40227463)
13. Kumar A., Haery C., Paladugu B., Kumar A., Symeoneides S., Taiberg L., Osman J., Trenholme G., Opal S. M., Goldfarb R., Parrillo J. E., The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. Journal of Infectious Diseases 2006 193 2 251 258 2-s2.0-30944463415 10.1086/498909 (Pubitemid 43113487)
14. Boucher H. W., Talbot G. H., Bradley J. S., Edwards J. E., Gilbert D., Rice L. B., Scheld M., Spellberg B., Bartlett J., Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Diseases 2009 48 1 1 12 10.1086/595011
15. Knaus W. A., Sun X., Nystrom P. O., Wagner D. P., Evaluation of definitions for sepsis. Chest 1992 101 6 1656 1662 2-s2.0-0026663756
16. Krieger J. N., Kaiser D. L., Wenzel R. P., Urinary tract etiology of bloodstream infections in hospitalized patients. Journal of Infectious Diseases 1983 148 1 57 62 2-s2.0-0020506171 (Pubitemid 13039312)
17. Leibovici L., Paul M., Poznanski O., Drucker M., Samra Z., Konigsberger H., Pitlik S. D., Monotherapy versus β -lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrobial Agents and Chemotherapy 1997 41 5 1127 1133 2-s2.0-0030970810 (Pubitemid 27194197)
18. Ibrahim E. H., Sherman G., Ward S., Fraser V. J., Kollef M. H., The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000 118 1 146 155 2-s2.0-0141610906 (Pubitemid 30485502)
19. Behrendt G., Schneider S., Brodt H. R., Just-Nübling G., Shah P. M., Influence of antimicrobial treatment on mortality in septicemia. Journal of Chemotherapy 1999 11 3 179 186 2-s2.0-0033056721 (Pubitemid 29321133)
20. Zaragoza R., Artero A., Camarena J. J., Sancho S., González R., Nogueira J. M., The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clinical Microbiology and Infection 2003 9 5 412 418 2-s2.0-0037870468 10.1046/j.1469-0691.2003.00656.x (Pubitemid 36758130)
21. Blot S., Vandewoude K., de Bacquer D., Colardyn F., Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clinical Infectious Diseases 2002 34 12 1600 1606 2-s2.0-0037097652 10.1086/340616 (Pubitemid 34615445)
22. Paul M., Shani V., Muchtar E., Kariv G., Robenshtok E., Leibovici L., Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrobial Agents and Chemotherapy 2010 54 11 4851 4863 2-s2.0-78049233262 10.1128/AAC.00627-10
23. Lodise T. P., McKinnon P. S., Swiderski L., Rybak M. J., Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clinical Infectious Diseases 2003 36 11 1418 1423 2-s2.0-0038468773 10.1086/375057 (Pubitemid 36702876)
24. Shorr A. F., Micek S. T., Welch E. C., Doherty J. A., Reichley R. M., Kollef M. H., Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Critical Care Medicine 2011 39 1 46 51 2-s2.0-78651257740 10.1097/CCM.0b013e3181fa41a7
25. Reisfeld S., Paul M., Gottesman B. S., Shitrit P., Leibovici L., Chowers M., The effect of empiric antibiotic therapy on mortality in debilitated patients with dementia. European Journal of Clinical Microbiology and Infectious Diseases 2011 30 6 813 818 2-s2.0-79956076173 10.1007/s10096-011-1161-x
26. Cortés J. A., Garzón D. C., Navarrete J. A., Contreras K. M., Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America. Revista Argentina de Microbiologia 2010 42 3 230 234 2-s2.0-77958065759
27. Permpikul C., Tongyoo S., Ratanarat R., Wilachone W., Poompichet A., Impact of septic shock hemodynamic resuscitation guidelines on rapid early volume replacement and reduced mortality. Journal of the Medical Association of Thailand 2010 93, supplement 1 S102 109 2-s2.0-77951914220
28. Kang C. I., Kim S. H., Park W. B., Lee K. D., Kim H. B., Kim E. C., Oh M. D., Choe K. W., Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrobial Agents and Chemotherapy 2005 49 2 760 766 2-s2.0-12944295224 10.1128/AAC.49.2.760-766.2005 (Pubitemid 40175690)
29. Zarkotou O., Pournaras S., Tselioti P., Dragoumanos V., Pitiriga V., Ranellou K., Prekates A., Themeli-Digalaki K., Tsakris A., Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clinical Microbiology and Infection 2011 17 12 1798 1803 2-s2.0-79956197541 10.1111/j.1469-0691.2011.03514.x
30. Johnson M. T., Reichley R., Hoppe-Bauer J., Dunne W. M., Micek S., Kollef M., Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Critical Care Medicine 2011 39 8 1859 1865 2-s2.0-79961026033 10.1097/CCM.0b013e31821b85f4
31. Abhilash K. P., Veeraraghavan B., Abraham O. C., Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. The Journal of the Association of Physicians of India 2010 58, supplement 13 17 2-s2.0-79960034125
32. Apisarnthanarak A., Buppunharun W., Tiengrim S., Sawanpanyalert P., Aswapokee N., An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. Journal of the Medical Association of Thailand 2009 92 S91 S94 2-s2.0-79952259914
33. Kiratisin P., Apisarnthanarak A., Laesripa C., Saifon P., Molecular characterization and epidemiology of extended-spectrum- β -lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrobial Agents and Chemotherapy 2008 52 8 2818 2824 2-s2.0-48749130645 10.1128/AAC.00171-08
34. Lucet J. C., Chevret S., Deeré D., Vanjak D., Macrez A., Bédos J. P., Wolff M., Regnier B., Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clinical Infectious Diseases 1996 22 3 430 436 2-s2.0-0029740750 (Pubitemid 26259170)
35. Pea C., Pujol M., Ardanuy C., Ricart A., Pallares R., Liares J., Ariza J., Gudiol F., Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum β -lactamases. Antimicrobial Agents and Chemotherapy 1998 42 1 53 58 2-s2.0-0344193098 (Pubitemid 28053326)
36. Paterson D. L., Ko W. C., Von Gottberg A., Mohapatra S., Casellas J. M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K. P., Bonomo R. A., Rice L. B., Wagener M. M., McCormack J. G., Yu V. L., International prospective study of Klebsiella pneumoniae Bacteremia: implications of extended-spectrum β -Lactamase production in Nosocomial infections. Annals of Internal Medicine 2004 140 1 26 32 2-s2.0-9144232354 (Pubitemid 38055918)
37. Rodríguez-Bao J., Picón E., Gijón P., Hernández J. R., Ruíz M., Pea C., Almela M., Almirante B., Grill F., Colomina J., Giménez M., Oliver A., Horcajada J. P., Navarro G., Coloma A., Pascual A., Community-onset bacteremia due to extended-spectrum β -lactamase- producing Escherichia coli: risk factors and prognosis. Clinical Infectious Diseases 2010 50 1 40 48 2-s2.0-72049128093 10.1086/649537
38. Paterson D. L., Ko W. C., Von Gottberg A., Mohapatra S., Casellas J. M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K. P., Bonomo R. A., Rice L. B., Wagener M. M., McCormack J. G., Yu V. L., Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β -lactamases. Clinical Infectious Diseases 2004 39 1 31 37 2-s2.0-3042706689 10.1086/420816 (Pubitemid 38879546)
39. Endimiani A., Luzzaro F., Perilli M., Lombardi G., Colì A., Tamborini A., Amicosante G., Toniolo A., Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum β -Lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin. Clinical Infectious Diseases 2004 38 2 243 251 2-s2.0-1642455995 10.1086/380645 (Pubitemid 38113033)
40. Oteo J., Pérez-Vázquez M., Campos J., Extended-spectrum β -lactamase producing Escherichia coli: changing epidemiology and clinical impact. Current Opinion in Infectious Diseases 2010 23 4 320 326 2-s2.0-77954879314 10.1097/QCO.0b013e3283398dc1
41. Kansakar P., Dorji D., Chongtrakool P., Mingmongkolchai S., Mokmake B., Dubbs P., Local dissemination of multidrug-resistant Acinetobacter baumannii clones in a Thai Hospital. Microbial Drug Resistance 2011 17 1 109 119 2-s2.0-79952372430 10.1089/mdr.2010.0062
42. Lolans K., Rice T. W., Munoz-Price L. S., Quinn J. P., Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrobial Agents and Chemotherapy 2006 50 9 2941 2945 2-s2.0-33748700252 10.1128/AAC.00116-06 (Pubitemid 44396395)
43. Anunnatsiri S., Tonsawan P., Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 2011 42 3 693 703 2-s2.0-79961064825
44. Dizbay M., Tunccan O. G., Sezer B. E., Hizel K., Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scandinavian Journal of Infectious Diseases 2010 42 10 741 746 2-s2.0-77956807999 10.3109/00365548.2010.489568
45. Tacconelli E., Cataldo M. A., de Pascale G., Manno D., Spanu T., Cambieri A., Antonelli M., Sanguinetti M., Fadda G., Cauda R., Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. Journal of Antimicrobial Chemotherapy 2008 62 5 1130 1137 2-s2.0-54549127390 10.1093/jac/dkn289
46. Jung J. Y., Park M. S., Kim S. E., Park B. H., Son J. Y., Kim E. Y., Lim J. E., Lee S. K., Lee S. H., Lee K. J., Kang Y. A., Kim S. K., Chang J., Kim Y. S., Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infectious Diseases 2010 10, article 228 2-s2.0-77954977077 10.1186/1471-2334-10-228
47. Levin A. S., Barone A. A., Peno J., Santos M. V., Marinho I. S., Arruda E. A. G., Manrique E. I., Costa S. F., Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clinical Infectious Diseases 1999 28 5 1008 1011 2-s2.0-0032939527 (Pubitemid 29203530)
48. Garnacho-Montero J., Ortiz-Leyba C., Jiménez-Jiménez F. J., Barrero-Almodóvar A. E., García-Garmendia J. L., Bernabeu-Wittell M., Gallego-Lara S. L., Madrazo-Osuna J., Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clinical Infectious Diseases 2003 36 9 1111 1118 2-s2.0-0038369924 10.1086/374337 (Pubitemid 36549630)
49. Koomanachai P., Tiengrim S., Kiratisin P., Thamlikitkul V., Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. International Journal of Infectious Diseases 2007 11 5 402 406 2-s2.0-34547735143 10.1016/j.ijid.2006.09.011 (Pubitemid 47239447)
50. Curcio D., Fernandez F., Vergara J., Vazquez W., Luna C. M., Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline. Journal of Chemotherapy 2009 21 1 58 62 2-s2.0-63049101658
51. Metan G., Alp E., Yildiz O., Percin D., Aygen B., Sumerkan B., Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections. Journal of Chemotherapy 2010 22 2 110 114 2-s2.0-77951555223
52. Paul M., Kariv G., Goldberg E., Raskin M., Shaked H., Hazzan R., Samra Z., Paghis D., Bishara J., Leibovici L., Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy 2010 65 12 2658 2665 2-s2.0-78149483462 10.1093/jac/dkq373 dkq373
53. Schneider-Lindner V., Delaney J. A., Dial S., Dascal A., Suissa S., Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerging Infectious Diseases 2007 13 7 994 1000 2-s2.0-34447266384 (Pubitemid 47048069)
54. Spindel S. J., Strausbaugh L. J., Jacobson C., Infections caused by Staphylococcus aureus in a Veterans' Affairs nursing home care unit: a 5-year experience. Infection Control and Hospital Epidemiology 1995 16 4 217 223 2-s2.0-0029285939
55. Szumowski J. D., Wener K. M., Gold H. S., Wong M., Venkataraman L., Runde C. A., Cohen D. E., Mayer K. H., Wright S. B., Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of hiv-infected men who. Clinical Infectious Diseases 2009 49 1 118 121 2-s2.0-66949178669 10.1086/599608
56. Kim S. H., Kim K. H., Kim H. B., Kim N. J., Kim E. C., Oh M. D., Choe K. W., Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy 2008 52 1 192 197 2-s2.0-37849048632 10.1128/AAC.00700-07
57. Kumar A., Safdar N., Kethireddy S., Chateau D., A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta- regression study. Critical Care Medicine 2010 38 8 1651 1664 2-s2.0-77954959272 10.1097/CCM.0b013e3181e96b91
58. Russell J. A., Management of sepsis. The New England Journal of Medicine 2006 355 16 1699 1713 2-s2.0-33750047495 10.1056/NEJMra043632 (Pubitemid 44583960)
59. Vogelaers D., de Bels D., Forêt F., Cran S., Gilbert E., Schoonheydt K., Blot S., Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation ratesa multicentre, observational survey in critically ill patients. International Journal of Antimicrobial Agents 2010 35 4 375 381 2-s2.0-77049125905 10.1016/j.ijantimicag.2009.11.015
60. Peleg A. Y., Hooper D. C., Hospital-acquired infections due to gram-negative bacteria. The New England Journal of Medicine 2010 362 19 1804 1813 2-s2.0-77952298917 10.1056/NEJMra0904124
61. Deuster S., Roten I., Muehlebach S., Implementation of treatment guidelines to support judicious use of antibiotic therapy. Journal of Clinical Pharmacy and Therapeutics 2010 35 1 71 78 2-s2.0-74349120757 10.1111/j.1365-2710.2009.01045.x
62. van Gastel E., Costers M., Peetermans W. E., Struelens M. J., Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. Journal of Antimicrobial Chemotherapy 2010 65 3 576 580 2-s2.0-77950303985 10.1093/jac/dkp470 dkp470
63. Raineri E., Pan A., Mondello P., Acquarolo A., Candiani A., Crema L., Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. American Journal of Infection Control 2008 36 4 283 290 2-s2.0-43049150444 10.1016/j.ajic.2007. 06.009 (Pubitemid 351622018)
64. Lesprit P., Merabet L., Fernandez J., Legrand P., Brun-Buisson C., Improving antibiotic use in the hospital: focusing on positive blood cultures is an effective option. Presse Medicale 2011 40 6 e297 e303 2-s2.0-79957667081 10.1016/j.lpm.2010.12.014
65. Diamantis S., Rioux C., Bonnal C., Papy E., Farfour E., Andremont A., Yeni P., Bouvet E., Lucet J. C., Evaluation of initial antibiotic therapy for bacteremia and role of an antibiotic management team for antibiotic stewardship. Medecine et Maladies Infectieuses 2010 40 11 637 643 2-s2.0-78649317126 10.1016/j.medmal.2010.06.002
66. Corona A., Bertolini G., Lipman J., Wilson A. P., Singer M., Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). Journal of Antimicrobial Chemotherapy 2010 65 6 1276 1285 10.1093/jac/dkq088
67. Harbarth S., Nobre V., Pittet D., Does antibiotic selection impact patient outcome? Clinical Infectious Diseases 2007 44 1 87 93 2-s2.0-33845708554 10.1086/510075 (Pubitemid 44968991)
68. Pea C., Gudiol C., Calatayud L., Tubau F., Domínguez M. A., Pujol M., Ariza J., Gudiol F., Infections due to Escherichia coli producing extended-spectrum β -lactamase among hospitalised patients: factors influencing mortality. Journal of Hospital Infection 2008 68 2 116 122 2-s2.0-39049155380 10.1016/j.jhin.2007.11.012